Key result
CHA2DS2-VASc score linked to ~4.5-fold higher late stroke odds per point in POAF >48h.
Why the study?
Postoperative atrial fibrillation is associated with thromboembolic and bleeding complications after cardiac surgery, yet whether POAF duration modifies the prognostic performance of the CHA2DS2-VASc score remained unclear.
Does postoperative atrial fibrillation duration (>48 hours vs ≤48 hours) modify the predictive value of the CHA2DS2-VASc score for early and late stroke in adults after cardiac surgery?
Cohort (n=378)
No
Does postoperative atrial fibrillation duration (>48 hours vs ≤48 hours) modify the predictive value of the CHA2DS2-VASc score for early and late stroke in adults after cardiac surgery?
The CHA2DS2-VASc score predicts late (>6 weeks) postoperative stroke only in cardiac surgery patients whose postoperative atrial fibrillation lasts more than 48 hours, highlighting the importance of arrhythmia duration in thromboembolic risk stratification.
Answers are grounded in this paper and cite their sources.
POAF duration may modify CHA2DS2-VASc utility for late stroke after cardiac surgery; leaves open need for prospective validation before guiding anticoagulation.
Background Postoperative atrial fibrillation (POAF) is the most common arrhythmia after cardiac surgery and is associated with thromboembolic and bleeding complications. Whether POAF duration modifies the prognostic performance of the CHA2DS2-VASc score remains unclear. Purpose To compare the early (in-hospital) and late (post-discharge) predictive value of the CHA2DS2-VASc score in patients with POAF lasting ≤48 hours versus >48 hours. Methods We conducted a retrospective single-center cohort study including consecutive adults who developed POAF after cardiac surgery between January 2020 and December 2023. POAF was defined as new-onset atrial fibrillation lasting >1 hour and/or requiring treatment. Outcomes were assessed during hospitalization, within 6 weeks, and beyond 6 weeks postoperatively. The CHA2DS2-VASc score was calculated for each patient and analyzed in relation to stroke occurrence. Endpoints included stroke (in-hospital, ≤6 weeks, and >6 weeks), clinically relevant bleeding, AF recurrence, and length of stay. Results Among 2,419 cardiac surgeries, 378 patients (16%) developed POAF (≤48 h: n=193; >48 h: n=185). POAF >48 hours were associated with higher in-hospital stroke rates (5.41% vs 1.55%), increased bleeding risk (OR 2.29; 95% CI 1.19–4.43), and longer hospitalization (10.8±5.66 vs 8.86±4.65 days; p<0.001). Within 6 weeks, stroke incidence was low and AF recurrence occurred in 12.5%, without significant between-group differences. The CHA2DS2-VASc score did not predict in-hospital stroke (p=0.859; p=0.994) or 6-week stroke (p=0.531). Beyond 6 weeks, the score was not predictive in the ≤48 h group (p=0.066), but independently predicted stroke in the >48 h group (OR 4.53 per point; 95% CI 1.44–14.28; p=0.010). Conclusions POAF lasting >48 hours identify a higher-risk subgroup with greater perioperative morbidity and prolonged hospitalization. The CHA2DS2-VASc score predicts late stroke only in patients with POAF >48 hours, suggesting that arrhythmia duration should be incorporated into postoperative thromboembolic risk stratification.
No takes yet. Share an insight, caveat, or question.
Taseva et al. (2026) conducted a cohort in Postoperative atrial fibrillation (POAF) after cardiac surgery (n=378). POAF lasting >48 hours (and CHA2DS2-VASc score) vs. POAF lasting ≤48 hours was evaluated on Late stroke (>6 weeks postoperatively) predicted by CHA2DS2-VASc score in POAF >48 hours (OR 4.53 per point, 95% CI 1.44-14.28, p=0.010). CHA2DS2-VASc score independently predicted late stroke (>6 weeks) in patients with POAF >48h, but not in those with POAF ≤48h.
Synapse has enriched 10 related papers. Consider them for comparative context: